BioCatalystWatch
MNPRWorkspace / MNPR / OverviewCompany library
Monopar Therapeutics logo

Monopar Therapeutics

Monopar Therapeutics (MNPR)

Website

Featured programme · ALXN1840

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

ALXN1840

Small molecule

Copper (Cu)

PreINDP1P2P3FilingApproved
MNPR-101

uPAR

MNPR-101

uPAR

MNPR-101

uPAR

PreINDP1P2P3FilingApproved
MNPR-101

uPAR

MNPR-101

uPAR

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MNPR PR & News

PR & News

MNPR SEC archive